Q96P20 (NLRP3_HUMAN) Homo sapiens (Human)

NACHT, LRR and PYD domains-containing protein 3 UniProtKBInterProSTRINGInteractive Modelling

1036 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6)

Available Structures

16 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of the NLRP3 decamer bound to the inhibitor CRID3 Heteromer
3-1036
10×ADP; 10×8GI;
Assess
Structure of NLRP3 and NEK7 complex Heteromer
Q8TDX7;
133-1035
7YN;ATP;
Assess
Cryo-EM structure of the active NLRP3 inflammasome disk Heteromer
Q8TDX7;
133-1034
10×AGS; 10×MG;
Assess
Cryo-EM structure of NLRP3 bound to NEK7 Heteromer
Q8TDX7;
135-1036
ADP;
Assess
NLRP3 PYD filamenthomo-21-mer1-95
Assess
Cryo-EM structure of the NLRP3 PYD filamenthomo-18-mer3-94
Assess
Cryo-EM structure of NLRP3 open octamerhomo-8-mer130-1035
Assess
Human NLRP3-deltaPYD hexamerhomo-6-mer134-1036
ADP;
Assess
Cryo-EM structure of NLRP3 closed hexamerhomo-6-mer133-1035
7YN;ATP;
Assess
Cryo-EM structure of PYD-deleted human NLRP3 hexamerhomo-6-mer135-1034
ADP;7YN;
Assess
Crystal structure of NLRP3 in complex with inhibitor NP3-562monomer134-679
A1H02;ADP;
Assess
NLRP3 NACHT domain in complex with compound 32monomer134-676
MG;ADP;XE3;
Assess
Crystal Structure of NLRP3 NACHT domain in complex with a potent inhibitormonomer134-676
RM5;ADP;
Assess
CryoEM Structure of NLRP3 NACHT domain in complex with G2394monomer134-676
MG;ADP;WTN;
Assess
3D NMR solution structure of NLRP3 PYDmonomer3-93
Assess
Crystal structure of NALP3 PYDmonomer5-94
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7pzc.1.Ahomo-10-mer0.773-1036
10×ADP; 10×8GI;100.00
Assess
8swf.1.Ahomo-8-mer0.67133-1035
100.00
Assess

15 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27pzc.1.Hmonomer0.783-918
ADP;8GI;88.34
Assess
Isoform 27pzc.1.Amonomer0.763-918
ADP;8GI;88.34
Assess
Isoform 26npy.1.Amonomer0.55135-918
87.88
Assess
Isoform 37pzc.1.Hmonomer0.743-692
ADP;8GI;100.00
Assess
Isoform 37pzc.1.Amonomer0.733-692
ADP;8GI;100.00
Assess
Isoform 38ej4.1.Amonomer0.69146-685
AGS;MG;100.00
Assess
Isoform 47pzc.1.Ahomo-10-mer0.773-979
10×ADP; 10×8GI;98.26
Assess
Isoform 48swf.1.Ahomo-8-mer0.67133-978
98.11
Assess
Isoform 48ej4.1.Amonomer0.66146-948
AGS;MG;85.18
Assess
Isoform 57pzc.1.Ahomo-10-mer0.773-979
10×ADP; 10×8GI;95.10
Assess
Isoform 58ej4.1.Amonomer0.67146-948
AGS;MG;92.78
Assess
Isoform 58swf.1.Ahomo-8-mer0.65133-978
94.57
Assess
Isoform 56npy.1.Amonomer0.55135-948
93.45
Assess
Isoform 67pzc.1.Ahomo-10-mer0.763-1016
10×ADP; 10×8GI;99.90
Assess
Isoform 68swf.1.Ahomo-8-mer0.66133-1015
99.89
Assess